Aarkstore - Blepharitis - Pipeline Review, H1 2015

1. Aarkstore - Blepharitis - Pipeline Review, H1 2015 www.aarkstore.com

2. Summary Global Markets Directs, “Blepharitis - Pipeline Review, H1 2015”, provides an overview of the Blepharitiss therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Blepharitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Blepharitis and special features on late-stage and discontinued projects. www.aarkstore.com

3. Scope - The report provides a snapshot of the global therapeutic landscape of Blepharitis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Blepharitis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Blepharitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Blepharitis pipeline on the basis of target, MoA, route of administration and molecule type www.aarkstore.com

4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Blepharitis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Blepharitis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope www.aarkstore.com

5. Table of Contents Introduction 5 Global Markets Direct Report Coverage 5 Blepharitis Overview 6 Therapeutics Development 7 Pipeline Products for Blepharitis - Overview 7 Pipeline Products for Blepharitis - Comparative Analysis 8 Blepharitis - Therapeutics under Development by Companies 9 Blepharitis - Pipeline Products Glance 10 www.aarkstore.com

6. List Of Tables Number of Products under Development for Blepharitis, H1 2015 7 Number of Products under Development for Blepharitis - Comparative Analysis, H1 2015 8 Number of Products under Development by Companies, H1 2015 9 Comparative Analysis by Late Stage Development, H1 2015 10 Comparative Analysis by Clinical Stage Development, H1 2015 11 Comparative Analysis by Early Stage Development, H1 2015 12 Comparative Analysis by Unknown Stage Development, H1 2015 13 Products under Development by Companies, H1 2015 14 www.aarkstore.com

7. List Of Figures Number of Products under Development for Blepharitis, H1 2015 7 Number of Products under Development for Blepharitis - Comparative Analysis, H1 2015 8 Number of Products under Development by Companies, H1 2015 9 Assessment by Monotherapy Products, H1 2015 19 Number of Products by Top 10 Targets, H1 2015 21 Number of Products by Stage and Top 10 Targets, H1 2015 22 Number of Products by Top 10 Mechanism of Actions, H1 2015 23 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 24 Number of Products by Top 10 Routes of Administration, H1 2015 25 www.aarkstore.com

8. Related Market Research reports: • Ocular Hypertension - Pipeline Review, H1 2015 • Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 • Actinic (Solar) Keratosis - Pipeline Review, H1 2015 • Allergic Rhino-Conjunctivitis - Pipeline Review, H1 2015 • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2015 www.aarkstore.com

9. Related Market Research reports: • Myocardial Ischemia - Pipeline Review, H1 2015 • Thalassemia - Pipeline Review, H1 2015 • Encephalomyelitis - Pipeline Review, H1 2015 • T-Cell Leukemia - Pipeline Review, H1 2015 • Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015 www.aarkstore.com

10. Aarkstore - Blepharitis - Pipeline Review, H1 2015 www.aarkstore.com

11. Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon,  Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614,  Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com